These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Analysis of Aleutian disease virus infection in vitro and in vivo: demonstration of Aleutian disease virus DNA in tissues of infected mink. Bloom ME, Race RE, Aasted B, Wolfinbarger JB. J Virol; 1985 Sep; 55(3):696-703. PubMed ID: 3894686 [Abstract] [Full Text] [Related]
6. Construction of pathogenic molecular clones of Aleutian mink disease parvovirus that replicate both in vivo and in vitro. Bloom ME, Fox JM, Berry BD, Oie KL, Wolfinbarger JB. Virology; 1998 Nov 25; 251(2):288-96. PubMed ID: 9837793 [Abstract] [Full Text] [Related]
9. Simultaneous identification of viral proteins and nucleic acids in cells infected with Aleutian mink disease parvovirus. Mori S, Wolfinbarger JB, Dowling N, Wei W, Bloom ME. Microb Pathog; 1990 Oct 25; 9(4):243-53. PubMed ID: 1965846 [Abstract] [Full Text] [Related]
10. Identification of aleutian mink disease parvovirus capsid sequences mediating antibody-dependent enhancement of infection, virus neutralization, and immune complex formation. Bloom ME, Best SM, Hayes SF, Wells RD, Wolfinbarger JB, McKenna R, Agbandje-McKenna M. J Virol; 2001 Nov 25; 75(22):11116-27. PubMed ID: 11602751 [Abstract] [Full Text] [Related]
11. Expression of Aleutian mink disease parvovirus capsid proteins in defined segments: localization of immunoreactive sites and neutralizing epitopes to specific regions. Bloom ME, Martin DA, Oie KL, Huhtanen ME, Costello F, Wolfinbarger JB, Hayes SF, Agbandje-McKenna M. J Virol; 1997 Jan 25; 71(1):705-14. PubMed ID: 8985402 [Abstract] [Full Text] [Related]
13. Pathogenesis of Aleutian mink disease parvovirus infection: effects of suppression of antibody response on viral mRNA levels and on development of acute disease. Alexandersen S, Storgaard T, Kamstrup N, Aasted B, Porter DD. J Virol; 1994 Feb 25; 68(2):738-49. PubMed ID: 8289377 [Abstract] [Full Text] [Related]
15. Passive transfer of antiviral antibodies restricts replication of Aleutian mink disease parvovirus in vivo. Alexandersen S, Larsen S, Cohn A, Uttenthal A, Race RE, Aasted B, Hansen M, Bloom ME. J Virol; 1989 Jan 25; 63(1):9-17. PubMed ID: 2535756 [Abstract] [Full Text] [Related]
16. Monoclonal antibodies against Aleutian disease virus distinguish virus strains and differentiate sites of virus replication from sites of viral antigen sequestration. Race RE, Chesebro B, Bloom ME, Aasted B, Wolfinbarger J. J Virol; 1986 Jan 25; 57(1):285-93. PubMed ID: 3001352 [Abstract] [Full Text] [Related]
17. Pathogenesis of aleutian mink disease parvovirus and similarities to b19 infection. Best SM, Bloom ME. J Vet Med B Infect Dis Vet Public Health; 2005 Jan 25; 52(7-8):331-4. PubMed ID: 16316395 [Abstract] [Full Text] [Related]
18. Aleutian mink disease: puzzles and paradigms. Bloom ME, Kanno H, Mori S, Wolfinbarger JB. Infect Agents Dis; 1994 Dec 25; 3(6):279-301. PubMed ID: 7889316 [Abstract] [Full Text] [Related]
19. Caspase activation is required for permissive replication of Aleutian mink disease parvovirus in vitro. Best SM, Wolfinbarger JB, Bloom ME. Virology; 2002 Jan 20; 292(2):224-34. PubMed ID: 11878925 [Abstract] [Full Text] [Related]
20. Characterization of chimeric full-length molecular clones of Aleutian mink disease parvovirus (ADV): identification of a determinant governing replication of ADV in cell culture. Bloom ME, Berry BD, Wei W, Perryman S, Wolfinbarger JB. J Virol; 1993 Oct 20; 67(10):5976-88. PubMed ID: 8396664 [Abstract] [Full Text] [Related] Page: [Next] [New Search]